[Cl:1][C:2]1[C:3]2[N:4]([C:8]([C:11]3[C:16]([F:17])=[CH:15][N:14]=[C:13](Cl)[N:12]=3)=[CH:9][N:10]=2)[CH:5]=[CH:6][CH:7]=1.[NH2:19][C@H:20]([C:22]1[CH:23]=[C:24]([CH:26]=[CH:27][CH:28]=1)[NH2:25])[CH3:21].C(=O)([O-])[O-].[K+].[K+]>CS(C)=O>[NH2:25][C:24]1[CH:23]=[C:22]([C@@H:20]([NH:19][C:13]2[N:12]=[C:11]([C:8]3[N:4]4[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[C:3]4=[N:10][CH:9]=3)[C:16]([F:17])=[CH:15][N:14]=2)[CH3:21])[CH:28]=[CH:27][CH:26]=190 mg of the 8-chloro-3-(2-chloro-5-fluoropyrimidin-4-yl)imidazo[1,2-a]pyridine [125-2] was dissolved in 3 mL of dimethylsulfoxide, then 46.6 mg of 3-[(1S)-1-aminoethyl]aniline and 100 mg of potassium carbonate were added thereto, and stirred at 60° C. for 5 hours. The reaction mixture was cooled back to room temperature, and purified by preparative reversed phase liquid chromatography. Thereto, a saturated aqueous solution of sodium hydrogen carbonate was added, and the mixture was extracted with chloroform. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The insolubles were filtered, the filtrate was concentrated under reduced pressure, and 25 mg of N-[(1S)-1-(3-aminophenyl)ethyl]-4-(8-chloroimidazo[1,2-a]pyridin-3-yl)-5-fluoropyrimidine-2-amine [125-3] was obtained as a brown oily product.
読み込み中…